Drugwatch.com is excited to announce the addition of three respected health care professionals to our network of expert contributors. Along with Drugwatch’s other…
Drugwatch’s senior writer Michelle Llamas has joined the National Center for Health Research’s PCORI COVID-19 Press Teleconference Advisory Board. The…
On Oct. 2, 2020, the Food and Drug Administration announced it had approved Bristol-Myers Squibb’s Opdivo (nivolumab) in combination with Yervoy (ipilimumab)…
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
